Zealand Pharma says Phase 2 trial shows petrelintide cuts weight up to 9.2% in obese type 2 diabetes patients
Bitget2026/10/07 17:14Zealand Pharma reported positive topline Phase 2 results for weekly petrelintide in overweight or obese adults with type 2 diabetes. The study met its main goal, showing meaningful weight loss and improved blood-sugar control versus placebo. Safety looked consistent with earlier testing, with few treatment stops tied to gastrointestinal side effects. Full trial results will be presented at a future scientific conference. A Phase 3a program with Roche has started, targeting about 7,000 participants across three registrational trials. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zealand Pharma A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610071313OMX_____CNEWS_EN_GNW1001276830_en) on October 07, 2026, and is solely responsible for the information contained therein.
- Zealand Pharma reported positive topline Phase 2 results for weekly petrelintide in overweight or obese adults with type 2 diabetes.
- The study met its main goal, showing meaningful weight loss and improved blood-sugar control versus placebo.
- Safety looked consistent with earlier testing, with few treatment stops tied to gastrointestinal side effects.
- Full trial results will be presented at a future scientific conference.
- A Phase 3a program with Roche has started, targeting about 7,000 participants across three registrational trials.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
